It is a well-established principle that even the most promising API, monoclonal antibody or therapeutic peptide can only be turned into an effective and marketable drug if formulated in such a way that it reaches the blood stream and is bioavailable.

Our online event will be a forum for regulators, academics and research scientists to discuss the development bottlenecks, identify market opportunities and share the innovations that are helping the pharmaceutical industry overcome the Bioavailability Challenge.

Contact us now if you are an expert in this field, or if your company has specific research that could be presented through a webinar or a white paper.

Fill the form to contact us!